Is RSH.AX stock a buy after the drop?

RSH.AX stock currently looks tactical for short-term traders, not long-term investors. The company has negative EPS and thin cash. If volume and momentum improve, small positions with tight stops could be considered.

What price targets apply to RSH.AX stock?

Short-term targets: conservative **A$0.06**, base **A$0.07**, stretch **A$0.10**. Set a protective stop near **A$0.025**. Targets depend on volume confirmation and company news.

How does Meyka AI rate RSH.AX stock?

Meyka AI rates RSH.AX with a score out of 100: **67.65 | Grade B | HOLD**. The grade balances sector comparison, growth, key metrics, and forecasts. Grades are informational, not investment advice.

What are the main risks for RSH.AX stock?

Major risks include negative operating cash flow, high price-to-sales, low liquidity, and limited institutional interest. These raise volatility and slippage risk during attempted bounces.

AU Stocks

RSH.AX Respiri Limited ASX at A$0.033 on 27 Feb 2026: Watch for oversold bounce

ByHuzaifa Zahoor February 27, 2026February 27, 2026

RSH.AX stock closed at A$0.033 on 27 Feb 2026 on the ASX, leaving the healthcare small-cap deeply oversold. Volume finished at 579,396 shares as price settled between A$0.03 and A$0.033. We see a classic oversold bounce setup after a YTD decline of 58.23%. This piece maps the catalysts, risks, and short-term levels for traders seeking a measured rebound in Respiri Limited on the Australian market.